1. ChemInform Abstract: Furanolabdanoid-Based 1,2,4-Oxadiazoles: Synthesis and Cytotoxic Activity
- Author
-
Elvira E. Shults, M. E. Mironov, Yurii V. Kharitonov, Andrey G. Pokrovsky, Makhmut M. Shakirov, and Mikhail A. Pokrovsky
- Subjects
Chemistry ,Stereochemistry ,Substituent ,General Medicine ,Terpenoid ,Terpene ,chemistry.chemical_compound ,Cell culture ,medicine ,Cytotoxic T cell ,Doxorubicin ,Cytotoxicity ,Selectivity ,medicine.drug - Abstract
Several 15,16-epoxy-8,13,14-labdatriene derivatives modified at the C-16 position with a 1,2,4-oxadiazole ring with various substituent in the 5-th position, were obtained via multistep synthesis from 16-formyl derivatives of natural diterpenoid lambertianic acid. The cytotoxicity of furanolabdanoid-based 1,2,4-oxadiazoles was evaluated against human cancer cells (CEM-13, MT-4, U-937, MCF-7, MDA-MB-231, MEL-8) using the conventional MTT assays. All the tested diterpenoid-oxadiazole hybrids displayed better cytotoxic activity then lambertianic acid. The activity and selectivity to the cell line increased even further in the compounds containing a chloromethyl substituent in the 5-th position of the 1,2,4-oxadiazole ring. Two of the synthesized compounds exhibited high cytotoxic activity against lymphoblastoid cell line CEM-13 (GI50 0.08-0.34 μM), which was higher that than of the comparative drug Doxorubicin. The antitumor mechanism may be related to apoptosis induction in U-937, MCF-7, and CEM-13 cells.
- Published
- 2016
- Full Text
- View/download PDF